Diabetes, Obesity and Metabolism

Metabolic syndrome - a new risk factor of coronary heart disease?
pp. 359-370(12)
Authors: Haffner, S.; Cassells, H. B.

Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure
pp. 371-378(8)
Authors: Altuntas, Y.; Ozen, B.; Ozturk, B.; Sengul, A.; Ucak, S.; Ersoy, O.; Karul, S.

Metabolic disorders associated with uncontrolled hypertension: Skaraborg hypertension and diabetes project
pp. 379-387(9)
Authors: Bøg-Hansen, E.; Lindblad, U.; Gullberg, B.; Melander, A.; Råstam, L.

A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor
pp. 388-396(9)
Authors: Novak, S.; Stapleton, L. M.; Litaker, J. R.; Lawson, K. A.

Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice
pp. 397-407(11)
Authors: Mackay, P.; Ynddal, L.; Andersen, J. V.; McCormack, J. G.

Addition of pramlintide to insulin therapy lowers HbA_1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets
pp. 408-414(7)
Authors: Hollander, P.; Ratner, R.; Fineman, M.; Strobel, S.; Shen, L.; Maggs, D.; Kolterman, O.; Weyer, C.

The neointimal response to endovascular injury is increased in obese Zucker rats
pp. 415-423(9)
Authors: Shelton, J.; Wang, D.; Gupta, H.; Wyss, J. M.; Oparil, S.; White, C. R.

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin
pp. 424-431(8)
Authors: Blonde, L.; Wogen, J.; Kreilick, C.; Seymour, A. A.

Duration of obesity is not a risk factor for type 2 diabetes mellitus, arterial hypertension and hyperlipidemia
pp. 432-437(6)
Authors: Hekimsoy, Z.; Oktem, I. K.

Comparison of thrice daily `high' vs. `medium' premixed insulin aspart with respect to evening and overnight glycaemic control in patients with type 2 diabetes
pp. 438-445(8)
Authors: Ejskjaer, N.; Rasmussen, M.; Kamp, N.; Lindholm, A.; Christiansen, J. S.

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes
pp. 446-454(9)
Authors: Christiansen, J. S.; Vaz, J. A.; Metelko, Z.; Bogoev, M.; Dedov, I.

Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats
pp. 455-461(7)
Authors: Ramachandran, B.; Kandaswamy, M.; Narayanan, V.; Subramanian, S.

Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes
pp. 462-467(6)
Authors: Harte, A. L.; McTernan, P. G.; McTernan, C. L.; Crocker, J.; Starcynski, J.; Barnett, A. H.; Matyka, K.; Kumar, S.

News and views
pp. 468-472(5)
Author: Holt, Richard

Acknowledgements to Reviewers
pp. 473-474(2)

Author & Keyword Indexes for volume 5
pp. 475-480(6)